KB
Kelash Bunkar
About Kelash Bunkar
Data last updated:
Kelash Bunkar is a Director at Regis Industries Limited (since 2025), Whole-Time Director at Biogen Pharmachem Industries Limited (since 2025) and Director at Amerise Biosciences Limited (since 2025). The companies operate in Financial Services, Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹18.09 Cr; the largest is Regis Industries Limited at ₹16.70 Cr (FY 2025). Earlier, Kelash Bunkar was an Additional Director at Amraworld Agrico Limited (2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Regis Industries Limited L51109WB1982PLC034759 | Director | 03 Feb 2025 | 1982 | ₹16.70 Cr (FY 2025) | Active |
 Biogen Pharmachem Industries Limited L51100GJ1995PLC026702 | Whole-Time Director | 05 Feb 2025 | 1995 | ₹1.20 Cr (FY 2025) | Active |
| Amerise Biosciences Limited L29199GJ1984PLC007195 | Director | 03 Feb 2025 | 1984 | ₹18.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Amraworld Agrico Limited L01110GJ1991PLC015846 | Additional Director | 03 Feb 2025 | 1991 | ₹45.9 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kelash Bunkar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kelash Bunkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kelash Bunkar
Kelash Bunkar currently holds 3 directorships: Regis Industries Limited (Director, since 03 Feb 2025, revenue ₹16.70 Cr (FY 2025)); Biogen Pharmachem Industries Limited (Whole-Time Director, since 05 Feb 2025, revenue ₹1.20 Cr (FY 2025)); Amerise Biosciences Limited (Director, since 03 Feb 2025, revenue ₹18.8 Lakh (FY 2025)).
Kelash Bunkar was first appointed on 03 Feb 2025 as Director at Regis Industries Limited.
The 3 current companies of Kelash Bunkar that report revenue have a combined latest revenue of ₹18.09 Cr: Regis Industries Limited ₹16.70 Cr (FY 2025); Biogen Pharmachem Industries Limited ₹1.20 Cr (FY 2025); Amerise Biosciences Limited ₹18.8 Lakh (FY 2025).
Kelash Bunkar held 1 earlier board appointment: Amraworld Agrico Limited (Additional Director, 03 Feb 2025 to 19 Aug 2025).
The current boards of Kelash Bunkar's companies include Aman Pravinkumar Patel (Regis Industries Limited), Chhayaben Maheshbhai Parmar (Regis Industries Limited), Kinjal Pankajbhai Dalal (Regis Industries Limited), Manish Prajapat (Regis Industries Limited), Manish Prajapat (Regis Industries Limited), Chandrakant Govindbhai Parmar (Biogen Pharmachem Industries Limited), among others.